L-Asparaginase-associated hyperlipidemia with hyperviscosity syndrome in a patient with T-cell lymphoblastic lymphoma.
Meyer
B
B
Hagen
W
W
Scheithauer
W
W
Ohler
L
L
Kornek
G V
GV
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects*; D001809:Blood Viscosity; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D016399:Lymphoma, T-Cell / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000139:chemically induced; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D013577:Syndrome
D000970:Antineoplastic Agents; D001215:Asparaginase